ACOR

Acorda Therapeutics
ACOR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

79 hedge funds and large institutions have $17.6M invested in Acorda Therapeutics in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 27 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

96% less call options, than puts

Call options by funds: $101K | Put options by funds: $2.41M

Holders
79
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$101K
Puts
$2.41M
Net Calls
Net Calls Change

Top Buyers

1
+$429K
2
+$333K
3
+$208K
4
Jane Street
Jane Street
New York
+$191K
5
PP
Paloma Partners
Connecticut
+$175K

Top Sellers

1
-$4.53M
2
-$3.35M
3
-$1.42M
4
State Street
State Street
Massachusetts
-$1.08M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$648K
Name Holding Trade Value Shares
Change 		Change in
Stake
101
–
102
–
103
–
104
–
105
–
106
–
107
–
108
–
109
–
110
–
111
–
112
–
113
–
114
–
115
–
116
–
117
–
118
–
1 2 3 4
5